Table 5 Child Health and Illness Profile-Child Edition, change from baseline based on data of the 3 placebo-controlled trials.
| Â | Children (n = 275) | Adolescents (n = 112) | ||
|---|---|---|---|---|
CHIP-CE items Mean change (SE) | Atomoxetine (n = 183) | Placebo (n = 92) | Atomoxetine (n = 72) | Placebo (n = 40) |
Total Score | 4.60 (0.62) | 2.06 (0.80) | 5.40 (0.94) | 2.48 (1.28) |
Satisfaction Domain | 2.11 (0.83) | 2.18 (1.07) | 2.88 (1.22) | 2.19 (1.65) |
Satisfaction With Health | 0.40 (0.75) | 2.06 (0.97) | 1.29 (1.21) | 2.57 (1.65) |
Satisfaction With Self | 3.45 (0.88) | 1.84 (1.14) | 3.84 (1.28) | 1.21 (1.73) |
Comfort Domain | 2.47 (0.65) | 1.34 (0.84) | 2.57 (0.93) | 1.33 (1.26) |
Physical Comfort | 0.68 (0.64) | 1.53 (0.83) | 0.91 (0.81) | -0.01 (1.10) |
Emotional Comfort | 3.37 (0.76) | 1.01 (0.99) | 3.34 (0.97) | 1.23 (1.31) |
Restricted Activity | 0.81 (0.67) | 0.49 (0.88) | 0.46 (1.20) | 2.20 (1.63) |
Risk Avoidance Domain | 4.63 (0.64) | 1.90 (0.82) | 7.27 (0.93) | 0.70 (1.28) |
Individual Risk Avoidance | 4.16 (0.67) | 0.82 (0.86) | 4.59 (1.15) | -0.95 (1.56) |
Threats to Achievement | 4.08 (0.66) | 2.12 (0.84) | 7.35 (0.98) | 1.53 (1.35) |
Resilience Domain | 3.20 (0.68) | 1.23 (0.88) | 1.00 (0.97) | 1.69 (1.32) |
Family Involvement | 1.69 (0.70) | 0.18 (0.91) | 0.19 (1.00) | 2.05 (1.35) |
Physical Activity | 1.08 (0.72) | 1.16 (0.92) | -2.15 (1.10) | -0.42 (1.49) |
Social Problem Solving | 3.54 (0.77) | 1.31 (0.99) | 3.26 (1.12) | 1.67 (1.56) |
Achievement Domain | 4.04 (0.60) | 0.68 (0.79) | 4.83 (0.86) | 2.13 (1.21) |
Academic Performance | 4.03 (0.68) | 1.01 (0.88) | 5.21 (0.91) | 2.00 (1.28) |
Peer Relations | 2.61 (0.57) | 0.30 (0.74) | 2.76 (0.80) | 0.52 (1.09) |